Pharmacokinetics and other risk factors for kanamycin-induced hearing loss in patients with multi-drug resistant tuberculosis

OBJECTIVE: The toxicity associated with the use of kanamycin includes irreversible hearing loss. There is limited data describing the relationship between hearing loss and kanamycin pharmacokinetics (PK). We explored the association of kanamycin PK with hearing loss in patients on MDR-TB treatment....

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Audiol
Autors principals: Ghafari, Nazanin, Court, Richard, Chirehwa, Maxwell Tawanda, Wiesner, Lubbe, Petersen, Lucretia, Maartens, Gary, Gumbo, Tawanda, McIlleron, Helen, Ramma, Lebogang
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7582222/
https://ncbi.nlm.nih.gov/pubmed/31739701
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14992027.2019.1690170
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars